Cart
sales@molnova.com
Salvigenin
CAS No. 19103-54-9
Salvigenin( —— )
Catalog No. M21116 CAS No. 19103-54-9
Salvigenin is a potent hMAO-A inhibitor has neuroprotective antitumor and immunomodulatory effects.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 143 | In Stock |
|
| 10MG | 237 | In Stock |
|
| 25MG | 402 | In Stock |
|
| 50MG | 581 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSalvigenin
-
NoteResearch use only, not for human use.
-
Brief DescriptionSalvigenin is a potent hMAO-A inhibitor has neuroprotective antitumor and immunomodulatory effects.
-
DescriptionSalvigenin is a potent hMAO-A inhibitor has neuroprotective antitumor and immunomodulatory effects.
-
In VitroSalvigenin (0-100 μM, 3 h) protects SH-SY5Y cells against H2O2-induced cell death.Salvigenin (0-100 μM, 2 h) significantly reduces ROS generation, increases the glutathione level, declines the extent of cell apoptosis and increases autophagy in H2O2-exposed SH-SY5Y cells. Cell Viability Assay Cell Line:SY5Y cells exposed to H2O2 (300 μM)Concentration:10, 25, 50, and 100 μM Incubation Time:3 h Result:Protected SH-SY5Y cells (best in 25 and 50μM) against H2O2-induced cell death.Apoptosis Analysis Cell Line:SY5Y cells exposed to H2O2 (300 μM)Concentration:10, 25, 50, and 100 μM Incubation Time:2 h Result:Significantly declined the extent of cell apoptosis induced by H2O2.Western Blot Analysis Cell Line:SY5Y cells exposed to H2O2 (300 μM)Concentration:10, 25, 50, and 100 μM Incubation Time:2 h Result:Reduced cleaved caspase-3 and Bax/Bcl-2 ratio. Reduced caspase-12 and calpain levels. Reduced the level of Atg7, Atg12, and LC3-II/ LC3-I.
-
In VivoSalvigenin (0-9.68 μg/mouse/day; i.p.; 4 or 12 days) shows antitumor and immunomodulatory effects on tumor bearing mice. Animal Model:MCF-7 cell bearing inbred female Balb/c mice, aged from six to eight weeks Dosage:3.65, 5.85 and 9.68 μg/mouse/day for four days or 12 days Administration:Intraperitoneal injectionResult:Showed a significant increase in DTH response in a dose-dependent manner. Significantly decreased the rate of tumor growth, increased lymphocyte proliferation index, increased the level of IFN-γ and decreased IL-4 production. Exhibited a significant decrease of the splenic CD4+CD25+Foxp3+ T lymphocytes.
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetMAO
-
RecptorhMAO-A
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number19103-54-9
-
Formula Weight328.32
-
Molecular FormulaC18H16O6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 20 mg/mL (60.92 mM)
-
SMILESCOc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1
-
Chemical Name5-hydroxy-67-dimethoxy-2-(4-methoxyphenyl)-4H-chromen-4-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sarvestani N N Sepehri H Delphi L et al. Eupatorin and Salvigenin Potentiate Doxorubicin-Induced Apoptosis and Cell Cycle Arrest in HT-29 and SW948 Human Colon Cancer Cells[J]. Asian Pacific Journal of Cancer Prevention Apjcp 2018 19(1):131-139.
molnova catalog
related products
-
BW-1370U87
BW-1370U87 is a reversible competitive monoamine oxidase-A inhibitor for the study of depression and other CNS disorders.
-
CHBO4
CHBO4 is an hMAO-B inhibitor that is potent, reversible, competitive and selective.The IC50 value of CHBO4 against hMAO-B in the CHBO assay was 0.031 μM, and the Ki value was 0.010 ± 0.005 μM.CHBO4 reduces cellular damage by scavenging intracellular reactive oxygen species (ROS), and can be used to study Parkinson's disease (PD).
-
A-804598
A-804598 is a competitive and selective P2X7 receptor antagonist (IC50: 10 nM, rat; 9 nM, mouse; 11 nM, human).
